Health Products Regulatory Authority (HPRA)

On World Health Day, we are sharing our guide on reporting suspected safety issues with medicines and medical devices, created in collaboration with our Patient Forum. This two-page guide provides information for patient organisations to share with their members. It is available from our website: https://lnkd.in/eh6tyZkC #WorldHealthDay #PatientSafety

On #WorldHealthDay find out how medicines and medical devices are regulated in Ireland to ensure they meet high standards of safety, effectiveness and quality for the people who use them.

In conjunction with Brightwater Executive, the HPRA are now recruiting for the role of Chief Executive. Learn more about this role and how you can apply for it: https://lnkd.in/g-zRCpWK Please note the closing date for applications is 5pm on 06/05/2025. Tá an HPRA, i gcomhar le Brightwater Executive, ag earcú anois do ról an Phríomhfheidhmeannaigh. Is féidir tuilleadh eolais a fháil faoin ról seo agus faoin mbealach le hiarratas a dhéanamh anseo: https://lnkd.in/g-zRCpWK Tabhair faoi deara gurb é 5pm an 06/05/2025 an dáta deiridh a nglacfar le hiarratais.

The following role is now open for applications: - Blood Tissues Organs Vigilance Assessor - Human Products Monitoring Please see the link to the full job description details below https://lnkd.in/ehaAYfJm The closing date for application is 04/05/2025

The HPRA today announced that its Chief Executive, Dr Lorraine Nolan, will step down from her role in December 2025 to pursue new career options. Dr Nolan has served as the Chief Executive of the HPRA for over nine years and, by the end of 2025, she will have completed two terms in this leadership role. During her tenure, she successfully transformed the HPRA's regulatory functions while expanding its operations and enhancing its national, European and international standing. Her strategic leadership during Brexit and the Covid-19 pandemic ensured the regulator's vital contribution nationally to the successful navigation of these challenges. Dr. Nolan has been centrally involved in the European medicines and medical devices regulatory networks. She has served as a member of the EMA Management Board, which she chaired from 2022-2025, and as a member of the HMA Management Group. Paying tribute, Professor Michael Donnelly, Chair of the HPRA, said “I wish to commend Dr Nolan for her unwavering leadership and dedication to the organisation. Her tenure has been marked by significant achievements and a hugely positive, enduring legacy. I want to express both my personal thanks and that of the Authority to Lorraine for her service and wish her every success with her future endeavours”. The Authority will shortly commence the process for recruitment of a new Chief Executive of the HPRA to take up the position from January 2026. Read more: https://lnkd.in/erG6vFUM

The following role is now open for applications: - Scientific Officer - Veterinary Assessment, Veterinary Sciences Please see the link to the full job description details below https://lnkd.in/ehaAYfJm The closing date for application is 13/04/2025 Táthar ag glacadh le hiarratais anois don ról seo a leanas: - Oifigeach Eolaíochta - Measúnú Tréidliachta, Na hEolaíochtaí Tréidliachta Féach ar an nasc thíos do shonraí iomlána an tsainchuntais poist https://lnkd.in/ehaAYfJm Is é 13/04/2025 an dáta deiridh a nglacfar le hiarratais

The following role is now open for applications: - Application Support Analyst – ICT and Business Services Please see the link to the full job description details below https://lnkd.in/ehaAYfJm The closing date for application is 18/04/2025 Táthar ag glacadh le hiarratais anois don ról seo a leanas: - Anailísí Tacaíochta Feidhmchláir - Seirbhísí TFC & Gnó Féach ar an nasc thíos do shonraí iomlána an tsainchuntais poist https://lnkd.in/ehaAYfJm Is é 18/04/2025 an dáta deiridh a nglacfar le hiarratais

For the first time, all 27 EU countries together with Iceland and Norway have collected and reported data on both sales and use of antimicrobials in animals in their countries. The findings are presented in the first European Sales and Use of Antimicrobials for Veterinary Medicine (#ESUAvet) annual surveillance report. This work is extremely important for tackling #antimicrobialresistance. The data cover the year 2023, the starting point of a regular exercise that will result in yearly reports. Read more about this in our latest news announcement: https://lnkd.in/eerpUpB6

The following role is now open for applications: - Assessor, Biologicals – Centralised and Clinical Trials Licensing– Human Products Authorisation and Registration Please see the link to the full job description details below https://lnkd.in/ehaAYfJm The closing date for application is 13/04/2025

With Heads of Medicines Agencies (HMA) we have published the joint EU medicines agencies' network strategy to 2028 titled 'Seizing opportunities in a changing medicines landscape'. Main take-aways from the strategy: 📌 Six focus areas include accessibility, data and #AI, innovation, #AntimicrobialResistance, supply chain security and network sustainability 📌 It emphasises EU competitiveness in medicines development, AI and adopts a One Health approach connecting human, animal, and environmental #health 📌 It was developed through extensive collaboration and public consultation, and will guide the European medicines regulatory network to 2028. Learn more about this in our news announcement: https://lnkd.in/guYDACgy